Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FW.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FW.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FW.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HN.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.61ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.61ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.61EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.61EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used